TERLIVAZ TERLIPRESSIN FOR INJECTION
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Oct 2018)
What this means for you
This application is over — abandoned 22 Oct 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86532781
- Mark type
- Design + words
- Filed
- 12 Feb 2015
- Published for opposition
- 21 Jul 2015
- Abandoned
- 22 Oct 2018
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of hepatorenal syndrome, also known as HRS, containing terlipressin
Owner
- Ikaria Therapeutics LLC, Hampton, NJ, US
- Ikaria Therapeutics LLC, Hampton, NJ, US
Prosecution history
- 22 Nov 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 22 Oct 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 22 Oct 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2018 — SOU EXTENSION 5 GRANTED
- 28 Feb 2018 — SOU EXTENSION 5 FILED
- 02 Mar 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Feb 2018 — SOU TEAS EXTENSION RECEIVED
- 14 Sept 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2017 — SOU EXTENSION 4 GRANTED
- 12 Sept 2017 — SOU EXTENSION 4 FILED
- 12 Sept 2017 — SOU TEAS EXTENSION RECEIVED
- 23 Aug 2017 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 08 Mar 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2017 — SOU EXTENSION 3 GRANTED